About Ipsen Limited
Ipsen Limited is the UK subsidiary of Ipsen, a global specialty-driven pharmaceutical company with total sales exceeding €1.1 billion in 2011. Ipsen's ambition is to become a global leader in the treatment of targeted debilitating diseases with a development strategy supported by three franchises: neurology, endocrinology and uro-oncology. Moreover, the Group has an active policy of partnerships. Research and Development is focused on innovative patient-driven programmes in the areas of peptides and toxins. In 2011, R&D expenditure totalled more than €250 million, greater than 21% of Group sales. The Group has total worldwide staff of close to 4,500 employees.
